AI-Powered MRI could spot breast cancer earlier in High-Risk women

NCT ID NCT07121972

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing whether using an artificial intelligence (AI) tool called Mirai to guide MRI screening can help find breast cancers earlier. Researchers will enroll 400 women aged 40-89 who are at high risk according to the AI model. Participants will receive a supplemental MRI scan, and the team will track how many cancers are detected within one year. The goal is to see if AI can better identify who needs extra screening beyond standard mammography.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Magnetic resonance imaging (MRI) and artificial intelligence (AI) algorithm
What this could lead to
If successful, this could show that AI can more accurately identify women who would benefit from MRI screening, potentially catching breast cancers earlier.
What could go wrong
This is a single-arm study without a comparison group, so it cannot prove AI-guided screening is better than standard care. The AI model may not perform as well in real-world settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University of California, San Diego

    NOT_YET_RECRUITING

    San Diego, California, 92093, United States

  • University of California, San Francisco

    RECRUITING

    San Francisco, California, 94143, United States

    Contact Email: •••••@•••••

  • University of Chicago Comprehensive Cancer Center

    NOT_YET_RECRUITING

    Chicago, Illinois, 60637, United States

  • University of Massachusetts Memorial Medical Center

    RECRUITING

    Worcester, Massachusetts, 01655, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.